Sai Life Sciences debuts on Dalal Street with 18% premium to issue price

Sai Life Sciences, one of the key players in the contract research, development, and manufacturing (CRDMO) sector, made its debut on the Indian stock exchanges today, December 18. Shares of the company hit Dalal Street with a premium of 18 per cent to the issue price.

On BSE it got listed at Rs 660 and on NSE it was listed at Rs 650.

Grey Market Premium

Ahead of its official listing of the public issue, Sai Life Sciences shares indicated a Grey Market Premium (GMP) of Rs 72, with an expected listing price of Rs 621 per share. This suggested a potential 13.11 per cent premium over the upper IPO price band of Rs 549.

Also Read Hindustan Aeronautics Share Price Today Highlights, 13 Dec, 2024: Hindustan Aeronautics on the radar Realme Neo7 launched with Dimensity 9300+, 7,000 mAh battery, and IP69 rating Sai Life Sciences IPO opens tomorrow: 6 key risks that you should know before you subscribe issue Discover the price of Narayana Murthy’s ultra-luxury flat in Bengaluru’s Kingfisher Towers

Also Read: Bumper Debut! Mobikwik shares list at 59% premium to issue price

IPO Details: A Mix of Fresh Issue and OFS

Sai Life Sciences IPO, a mainboard issue concluded its subscription phase last week, that is from December 11 to December 13 captured investor interest.

The mainboard IPO, it was a book-built issue, valued at Rs 3,042.62 crores. Furthermore, the issue comprised two components where, the fresh issue featuring 1.73 crore shares, aggregating Rs 950 crores, and Offer for Sale (OFS) of 3.81 crore shares, amounting to Rs 2,092.62 crores.

The price band for the public issue was set between Rs 522 and Rs 549 per share, with retail investors needing a minimum investment of Rs 14,823 for one lot of 27 shares. Larger investors could opt for more substantial investments, such as Rs 2,07,522 for 14 lots or Rs 10,07,964 for 68 lots.

Also Read: Vishal Mega Mart sees a strong debut; lists at 33% premium to issue price on NSE

Who Managed the IPO?

The IPO was managed by prominent book-running lead managers such as Kotak Mahindra Capital, Jefferies India, Morgan Stanley India, PIIFL Securities,

The share allocation and related processes were handled by KFin Technologies,

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s